Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA

Abstract Background Although effective in reducing relapse rate and delaying progression, current therapies for multiple sclerosis (MS) do not completely halt disease progression. T cell autoimmunity to myelin antigens is considered one of the main mechanisms driving MS. It is characterized by autor...

Full description

Bibliographic Details
Main Authors:	Judith Derdelinckx, María José Mansilla, Maxime De Laere, Wai-Ping Lee, Juan Navarro-Barriuso, Inez Wens, Irene Nkansah, Jasmijn Daans, Hans De Reu, Aneta Jolanta Keliris, Johan Van Audekerke, Verdi Vanreusel, Zoë Pieters, Annemie Van der Linden, Marleen Verhoye, Geert Molenberghs, Niel Hens, Herman Goossens, Barbara Willekens, Patrick Cras, Peter Ponsaerts, Zwi N. Berneman, Eva María Martínez-Cáceres, Nathalie Cools
Format:	Article
Language:	English
Published:	BMC 2019-08-01
Series:	Journal of Neuroinflammation
Subjects:	Messenger RNA electroporation Tolerogenic dendritic cells Antigen-specific treatment Experimental autoimmune encephalomyelitis Multiple sclerosis Tolerance induction
Online Access:	http://link.springer.com/article/10.1186/s12974-019-1541-1

Similar Items

Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation
by: Maxime De Laere, et al.
Published: (2018-01-01)

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner
by: Mats Van Delen, et al.
Published: (2022-12-01)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
by: Neda Djedovic, et al.
Published: (2019-02-01)

Make immunological peace not war: Potential applications of tolerogenic dendritic cells
by: Emma Louise Walton
Published: (2017-04-01)

The Effects of Tamoxifen on Tolerogenic Cells in Cancer
by: Ros Akmal Mohd Idris, et al.
Published: (2022-08-01)

Searching for the Transcriptomic Signature of Immune Tolerance Induction—Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages
by: Juan Navarro-Barriuso, et al.
Published: (2018-09-01)

Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
by: Matthias P. Domogalla, et al.
Published: (2017-12-01)

Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
by: Ji-Hee Nam, et al.
Published: (2021-04-01)

Tolerogenic IDO+ dendritic cells are induced by PD-1-expressing mast cells
by: Cecilia Pessoa Rodrigues, et al.
Published: (2016-01-01)

Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review
by: Chiara Puricelli, et al.
Published: (2022-08-01)

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness
by: Juan Navarro-Barriuso, et al.
Published: (2021-01-01)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
by: Juan Navarro-Barriuso, et al.
Published: (2019-06-01)

The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential
by: Mohammed Ghiboub, et al.
Published: (2023-05-01)

CD40 Knocked Down Tolerogenic Dendritic Cells Decrease Diabetic Injury
by: Aziz Mahmoudzadeh, et al.
Published: (2017-12-01)

Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
by: Aurelie eMoreau, et al.
Published: (2012-08-01)

Functionalization-dependent effects of cellulose nanofibrils on tolerogenic mechanisms of human dendritic cells
by: Tomić S, et al.
Published: (2018-10-01)

Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis
by: Rachel Spiering, et al.
Published: (2019-11-01)

Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
by: Eros Marín, et al.
Published: (2018-02-01)

Gene expression profiling of human monocyte-derived dendritic cells - Searching for molecular regulators of tolerogenicity
by: Katina eSchinnerling, et al.
Published: (2015-10-01)

Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis
by: Inès R. H. Ben-Nejma, et al.
Published: (2019-11-01)

Tolerogenic Transcriptional Signatures of Steady-State and Pathogen-Induced Dendritic Cells
by: Emilia Vendelova, et al.
Published: (2018-02-01)

Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus
by: Patcharee Ritprajak, et al.
Published: (2019-10-01)

Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs
by: Seyed-Alireza Esmaeili, et al.
Published: (2021-11-01)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
by: Judith Derdelinckx, et al.
Published: (2021-02-01)

The Evaluation of the Effect of Tolerogenic Probiotics on the Maturation of Healthy Dendritic Cells versus Immature Dendritic Cells
by: Maryam Rastin, et al.
Published: (2023-03-01)

Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator
by: María José Mansilla, et al.
Published: (2021-07-01)

HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells
by: Cecilia Svanberg, et al.
Published: (2022-08-01)

Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease
by: Fatemeh Banisharif-Dehkordi, et al.
Published: (2019-01-01)

Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies
by: Maaike Suuring, et al.
Published: (2021-07-01)

Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease
by: Brett Eugene Phillips, et al.
Published: (2017-10-01)

Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles
by: Han Qiao, et al.
Published: (2022-07-01)

Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging
by: Fiona Cooke, et al.
Published: (2022-10-01)

Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
by: Jessica S. Suwandi, et al.
Published: (2017-11-01)

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
by: Georgina Flórez-Grau, et al.
Published: (2018-05-01)

Tolerogenic dendritic cells in radiation-induced lung injury
by: Benbo Liu, et al.
Published: (2024-01-01)

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
by: Brett Eugene Phillips, et al.
Published: (2019-02-01)

Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature
by: Harry Robertson, et al.
Published: (2021-10-01)

New DiaP277 analogue shifts DCs to tolerogenic, and modulates NF-Kβ1 to suppress autoreactive T lymphocytes in the type 1 diabetic mice
by: Murad Alahdal, et al.
Published: (2018-07-01)

Bone marrow dendritic cells deficient for CD40 and IL-23p19 are tolerogenic in vitro
by: Tahereh kalantari, et al.
Published: (2020-03-01)

Treatment with dexamethasone and monophosphoryl lipid A removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic features
by: Paulina Andrea García-González, et al.
Published: (2016-10-01)